Tian Sun

Tian Sun is a Research Analyst at Ally Bridge Group, based in New York, NY, where she specializes in investment research within the healthcare and life sciences sector, with a particular focus on biopharma and therapeutics assets. Her role involves conducting fundamental analysis, tracking industry trends, and supporting investment decisions for Ally Bridge Group's public and private equity strategies.

Prior to joining Ally Bridge Group in 2021, Tian Sun worked as an Equity Research Associate at Needham & Company, where she analyzed public biotechnology and healthcare companies, and as a Pharmacist at Jersey City Medical Center - Barnabas Health, lending deep domain expertise to her investment work. Her unique combination of healthcare practice and equity research experience equips her with a robust understanding of both clinical and financial aspects of life sciences investments.

Tian holds a degree from Rutgers University and leverages her scientific background to inform diligence on medical innovation, therapeutics, and biotechnology companies. Her analytical skillset and cross-disciplinary experience make her a valued contributor to Ally Bridge Group's healthcare investment initiatives.